Short interest in CARISMA Therapeutics Inc (NASDAQ:CARM) increased during the last reporting period, rising from 437.88K to 714.37K. This put 2.13% of the company's publicly available shares short.

Short interest for CARISMA Therapeutics gives investors a sense of the degree to which investors are betting on the decline of CARISMA Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 776.04K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.